Literature DB >> 32931912

Mycophenolic anilides as broad specificity inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors.

Seungheon Lee1, Angela F Ku2, Mohana Rao Vippila1, Yong Wang1, Minjia Zhang3, Xingyou Wang3, Lizbeth Hedstrom4, Gregory D Cuny5.   

Abstract

Inosine-5'-monophosphate dehydrogenase (IMPDH) is a potential target for microorganisms. However, identifying inhibitor design determinants for IMPDH orthologs continues to evolve. Herein, a series of mycophenolic anilide inhibitors of Cryptosporidium parvum and human IMPDHs are reported. Furthermore, molecular docking of 12 (e.g. SH-19; CpIMPDH Ki,app = 0.042 ± 0.015 µM, HsIMPDH2 Ki,app = 0.13 ± 0.05 µM) supports different binding modes with the two enzymes. For CpIMPDH the inhibitor extends into a pocket in an adjacent subunit. In contrast, docking suggests the inhibitor interacts with Ser276 in the NAD binding site in HsIMPDH2, as well as an adjacent pocket within the same subunit. These results provide further guidance for generating IMPDH inhibitors for enzymes found in an array of pathogenic microorganisms, including Mycobacterium tuberculosis.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Binding mode; Cryptosporidium parvum; IMPDH; Inhibitor; Inosine-5’-monophosphate dehydrogenase

Mesh:

Substances:

Year:  2020        PMID: 32931912      PMCID: PMC9511823          DOI: 10.1016/j.bmcl.2020.127543

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.940


  33 in total

1.  Structural determinants of inhibitor selectivity in prokaryotic IMP dehydrogenases.

Authors:  Deviprasad R Gollapalli; Iain S Macpherson; George Liechti; Suresh Kumar Gorla; Joanna B Goldberg; Lizbeth Hedstrom
Journal:  Chem Biol       Date:  2010-10-29

2.  Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.

Authors:  Sivapriya Kirubakaran; Suresh Kumar Gorla; Lisa Sharling; Minjia Zhang; Xiaoping Liu; Soumya S Ray; Iain S Macpherson; Boris Striepen; Lizbeth Hedstrom; Gregory D Cuny
Journal:  Bioorg Med Chem Lett       Date:  2012-01-24       Impact factor: 2.823

3.  Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase.

Authors:  P Kuzmic
Journal:  Anal Biochem       Date:  1996-06-01       Impact factor: 3.365

4.  Repurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents.

Authors:  Kavitha Mandapati; Suresh Kumar Gorla; Amanda L House; Elizabeth S McKenney; Minjia Zhang; Suraj Nagendra Rao; Deviprasad R Gollapalli; Barbara J Mann; Joanna B Goldberg; Gregory D Cuny; Ian J Glomski; Lizbeth Hedstrom
Journal:  ACS Med Chem Lett       Date:  2014-06-10       Impact factor: 4.345

Review 5.  Mycophenolate revisited.

Authors:  Teun van Gelder; Dennis A Hesselink
Journal:  Transpl Int       Date:  2015-05       Impact factor: 3.782

6.  The structural basis of Cryptosporidium -specific IMP dehydrogenase inhibitor selectivity.

Authors:  Iain S Macpherson; Sivapriya Kirubakaran; Suresh Kumar Gorla; Thomas V Riera; J Alejandro D'Aquino; Minjia Zhang; Gregory D Cuny; Lizbeth Hedstrom
Journal:  J Am Chem Soc       Date:  2010-02-03       Impact factor: 15.419

7.  Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.

Authors:  Liqiang Chen; Daniel Wilson; Hiremagalur N Jayaram; Krzysztof W Pankiewicz
Journal:  J Med Chem       Date:  2007-11-27       Impact factor: 7.446

8.  Characterization of human type I and type II IMP dehydrogenases.

Authors:  S F Carr; E Papp; J C Wu; Y Natsumeda
Journal:  J Biol Chem       Date:  1993-12-25       Impact factor: 5.157

9.  A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.

Authors:  Lisa Sharling; Xiaoping Liu; Deviprasad R Gollapalli; Sushil K Maurya; Lizbeth Hedstrom; Boris Striepen
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

10.  A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.

Authors:  Magdalena Makowska-Grzyska; Youngchang Kim; Natalia Maltseva; Jerzy Osipiuk; Minyi Gu; Minjia Zhang; Kavitha Mandapati; Deviprasad R Gollapalli; Suresh Kumar Gorla; Lizbeth Hedstrom; Andrzej Joachimiak
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

View more
  2 in total

1.  SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome.

Authors:  Michela Zaffagni; Jenna M Harris; Ines L Patop; Nagarjuna Reddy Pamudurti; Sinead Nguyen; Sebastian Kadener
Journal:  Elife       Date:  2022-03-16       Impact factor: 8.713

2.  Novel amides of mycophenolic acid and some heterocyclic derivatives as immunosuppressive agents.

Authors:  Juliusz Maksymilian Walczak; Dorota Iwaszkiewicz-Grześ; Michalina Ziomkowska; Magdalena Śliwka-Kaszyńska; Mateusz Daśko; Piotr Trzonkowski; Grzegorz Cholewiński
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.